as on December 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.14%
Downside
8.70%
Upside
52 Week's Low
52 Week's High
14.98%
Downside
201.55%
Upside
as on December 8, 2025 at 4:01 pm IST
Market Cap
₹257.75 Cr
Return on Equity (ROE)
23.03
PE Ratio (TTM)
0Return on capital employed (ROCE)
21.13
Beta (LTM)
0.82
P/B Ratio
3.76
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-20.87
EPS (TTM)
2.76
Sector
FMCG
Book Value
21.01
Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Indo US Bio-Tech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 257.75 | 128.69% | 0.00 | 5 | 50 | |
| NA | 166.73 | 24.4% | 0.73 | 10 | 103 | |
| BUY | 13,038.23 | 2.19% | 0.52 | 346 | 2,708 | |
| NA | 188.63 | 11.49% | 0.78 | 1 | 286 | |
| BUY | 5,289.39 | 19.57% | 0.54 | 249 | 4,612 |
Investment in Indo US Bio-Tech Ltd Shares on INDmoney has grown by 2712.50% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:2712.50% versus previous 30 day period
Search interest for Indo US Bio-Tech Ltd Stock has increased by 556% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:556% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Indo US Bio-Tech Ltd.
Indo US Bio-Tech Ltd’s net profit fell -20.87% since last year same period to ₹3.45Cr in the Q2 2025-2026. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -26.6% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2024, Indo US Bio-Tech Ltd has declared dividend of ₹0.25 per share on 21 Nov 2024 - translating a dividend yield of 0.19%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 188.0% return, outperforming this stock by 109.5%
Against Peers
![]()
In the last 1 year, Vimta Labs Ltd has given 31.9% return, outperforming this stock by 94.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 70.17% of holdings in Sep 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 29.83% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 1 year, INDOUS stock has moved down by -62.1%
| Organisation | Indo US Bio-Tech Ltd |
| Industry | FMCG |
| CEO | Jagdish Ajudia |
| E-voting on shares | Click here to vote |
Indo US Bio-Tech Ltd share price today stands at ₹128.8 as on at the close of the market. Indo US Bio-Tech Ltd share today touched a day high of ₹140 and a low of ₹127.33.
Indo US Bio-Tech Ltd touched a 52 week high of ₹388.4 and a 52 week low of ₹109.5. Indo US Bio-Tech Ltd share price today i.e. is closed at ₹128.8, which is -66.84% down from its 52 week high and 17.63% up from its 52 week low.
Indo US Bio-Tech Ltd market capitalisation is ₹257.75 Cr as on .
To buy Indo US Bio-Tech Ltd shares, you need to follow these steps:
Indo US Bio-Tech Ltd trading volume is 1.09L as on . This means that 1.09L shares of Indo US Bio-Tech Ltd were bought and sold on the stock market during today's trading session.